4WEALTH Advisors Inc. Makes New $848,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

4WEALTH Advisors Inc. acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 1,624 shares of the medical equipment provider's stock, valued at approximately $848,000. Intuitive Surgical accounts for approximately 0.8% of 4WEALTH Advisors Inc.'s investment portfolio, making the stock its 27th largest holding.

Other hedge funds and other institutional investors have also modified their holdings of the company. Atala Financial Inc bought a new stake in Intuitive Surgical during the 4th quarter worth about $25,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the fourth quarter valued at about $28,000. Finally, Hurley Capital LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $28,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 0.3 %

Shares of NASDAQ ISRG opened at $517.18 on Friday. The stock has a market cap of $185.37 billion, a P/E ratio of 80.68, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a twelve month low of $367.39 and a twelve month high of $616.00. The stock has a 50 day moving average of $505.20 and a two-hundred day moving average of $533.22.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period last year, the company posted $1.50 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the topic of several research reports. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective on the stock. Erste Group Bank downgraded shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Robert W. Baird decreased their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Finally, Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares of the company's stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,313 shares of company stock valued at $17,229,143. 0.70% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.